Industry Presentations



  • NON

    Are You Ready for Biosimilars? What the Oncology Team Should Know

    Speakers:Gary Cohen, MD, FACP, FASCO

    Duration: 30 minutes

    Presented on: May 30, 2019

    *This session is not eligible for AMA PRA Category 1 CreditsTM


  • Gary Cohen, MD, FACP, FASCO

    Gary Cohen, MD, FACP, FASCO

    Gary Cohen, MD, FACP, FASCO

    Dr. Gary Cohen is Director Emeritus, of the Sandra and Malcolm Berman Cancer Institute at Greater Baltimore Medical Center (GBMC). He completed his undergraduate training at Duke University and graduated medical school at the University of Maryland. He subsequently completed his fellowship training in medical oncology at the Dana Farber Cancer Institute of Harvard University. During that time he also completed a fellowship in hematology. He currently holds an appointment as Associate Professor in the Department of Oncology at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and is board certified in internal medicine, medical oncology and hematology. He is a Fellow of the American Society of Clinical Oncology and Fellow of the American College of Physicians.

    Dr. Cohen established The Cancer Center at GBMC after being appointed Director in 1990. The Center has been listed by US News and World Report as one of the top 50 cancer programs in the U.S.

    He has co-authored numerous articles in the medical literature on various aspects of clinical cancer research. Dr. Cohen has been an active participant in the ECOG-ACRIN national cooperative clinical trials group, chairs the Community Scientific Committee, serves as community co-chair of the Melanoma Committee and sits on the ECOG-ACRIN Executive Council. He is a Founder and Board Member of Gilchrist Hospice Care in Baltimore. He has served on many committees and boards for health-related organizations including the Board of Directors of American Society of Clinical Oncology and Chair of the ASCO Measures Task Force (Quality Care Committee). He served for 20 years as Administrative Director of the Sidney Kimmel Foundation for Cancer Research, which awarded over $3 million dollars per year to outstanding young cancer scientists. He has won house staff teaching awards on several occasions and has regularly been listed in local (Baltimore Magazine) and national physician surveys as "Best Doctor” in Oncology.